BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 21620067)

  • 1. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. University of Modena experience in HIV-positive patients undergoing liver transplantation.
    Di Benedetto F; Tarantino G; De Ruvo N; Cautero N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; Serra V; Rompianesi G; D'Amico G; Mimmo A; Iemmolo RM; Codeluppi M; Cocchi S; Guaraldi G; Gerunda GE
    Transplant Proc; 2011 May; 43(4):1114-8. PubMed ID: 21620066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in HIV-positive patients.
    Vennarecci G; Ettorre GM; Antonini M; Santoro R; Perracchio L; Visco G; Santoro E
    Transplant Proc; 2007; 39(6):1936-8. PubMed ID: 17692658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients.
    Schreibman I; Gaynor JJ; Jayaweera D; Pyrsopoulos N; Weppler D; Tzakis A; Schiff ER; Regev A
    Transplantation; 2007 Sep; 84(6):697-705. PubMed ID: 17893602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
    Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
    Umbro I; Tinti F; Mordenti M; Rossi M; Ianni S; Pugliese F; Ruberto F; Ginanni Corradini S; Nofroni I; Poli L; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation.
    Di Benedetto F; Di Sandro S; De Ruvo N; Montalti R; Ballarin R; Guerrini GP; Spaggiari M; Guaraldi G; Gerunda G
    Transplantation; 2010 Mar; 89(6):733-8. PubMed ID: 20048692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.